An association between BRAF mutation and elevated mTOR pathway activation was observed in skin melanomas, whereas in a series of uveal melanomas no association was found between mTOR pathway activation and GNAQ mutation (Populo et al., 2011a; Populo et al., 2011b). Here, MTOR is linked to cutaneous melanoma.